Impact of the timing of tumor assessments on median progression-free survival in clinical trials in advanced cancer patients

por Samaille, T., Moreau Bachelard, C., Coquan, E., du Rusquec, P., Paoletti, X., Le Tourneau, C.
Publicado 2021

Evaluation of the relevance of the growth modulation index (GMI) from the FFCD 0307 randomized phase III trial comparing the sequence of two chemotherapeutic regimens

por du Rusquec, P., Guimbaud, R., Le Malicot, K., Gornet, J.-M., Nguyen, S., Lecomte, T., Khemissa-Akouz, F., Perrier, H., Bouché, O., Paoletti, X., Le Tourneau, C.
Publicado 2023